Hematoma of Rectus Sheath Following Subcutaneous Enoxaparin Injection
Anticoagulation drugs are frequently used to prevent deep vein thrombosis in high-risk patients. Subcutaneous low molecular weight heparin (LMWH) is increasingly used in both hospitalized patients and outpatient settings. This necessitates familiarity of both health care providers and patients with...
Main Authors: | Shahram Firoozbakhsh, Reza Parsaei, Reyhaneh Jafarshad |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2013-05-01
|
Series: | Acta Medica Iranica |
Subjects: | |
Online Access: | https://acta.tums.ac.ir/index.php/acta/article/view/4436 |
Similar Items
-
Hematoma of Rectus Sheath Following Subcutaneous Enoxaparin Injection
by: Shahram Firoozbakhsh, et al.
Published: (2013-05-01) -
Recombinant Activated Factor VII Treatment of Life-Threatening Rectus Sheath Hematoma in a Patient Receiving Enoxaparin, Aspirin, and Clopidogrel: A Case Report
by: Isawaruk Poonsawas, et al.
Published: (2020-07-01) -
Rectus sheath hematoma associated with apixaban
by: Kulothungan Gunasekaran, et al.
Published: (2017-08-01) -
Continuous rectus sheath block in a patient with a postoperative rectus sheath hematoma: a case report
by: Sho Kumita, et al.
Published: (2019-03-01) -
Fatal spontaneous rectus sheath hematoma in a patient with cirrhosis
by: McCarthy Danielle, et al.
Published: (2010-01-01)